Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02227732
Study type Interventional
Source CareFusion
Contact
Status Completed
Phase N/A
Start date April 2014
Completion date May 2015

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05543330 - A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC Phase 1/Phase 2
Completed NCT00758316 - A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions Phase 3
Completed NCT03869697 - Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions Phase 1
Enrolling by invitation NCT02092155 - Biomarker Levels During Indwelling Pleural cAtheter Sample Testing
Recruiting NCT00430664 - A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis N/A
Completed NCT00188474 - A Quality of Life Study re Management of Malignant Pleural Effusions N/A
Terminated NCT02623959 - Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis Phase 4